{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:05:25Z","timestamp":1761609925875},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jbspin.2017.08.005","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T05:16:03Z","timestamp":1505366163000},"page":"461-468","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Poor efficacy of TNF inhibitors in non-radiographic axial spondyloarthritis in the absence of objective signs: A bicentric retrospective study"],"prefix":"10.1016","volume":"85","author":[{"given":"C\u00e9line","family":"Vidal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9dric","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Combe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Berenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves Marie","family":"Pers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00e9mie","family":"Sellam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Morel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2017.08.005_bib0175","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","article-title":"Spondyloarthritis","volume":"377","author":"Dougados","year":"2011","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0180","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/BOR.0b013e32833ac5cc","article-title":"New approaches to diagnosis and classification of axial and peripheral spondyloarthritis","volume":"22","author":"Rudwaleit","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0185","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of spondyloarthritis international Society classification criteria for axial spondyloarthritis (part\u00a0II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0190","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/annrheumdis-2013-203419","article-title":"Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0195","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.39298","article-title":"American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"68","author":"Ward","year":"2016","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0200","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/art.23606","article-title":"Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a 12-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week\u00a052","volume":"58","author":"Haibel","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0205","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/annrheumdis-2012-201766","article-title":"Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)","volume":"72","author":"Sieper","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2013-204231","article-title":"Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled phase\u00a03 study","volume":"73","author":"Landewe","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0215","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jdv.12562","article-title":"Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review","volume":"28","author":"Rouzaud","year":"2014","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0220","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.38140","article-title":"Tumor necrosis factor \u03b1 inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort","volume":"65","author":"Ciurea","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0225","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/art.38721","article-title":"Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial: efficacy of etanercept in nonradiographic axial SpA","volume":"66","author":"Dougados","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0230","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1002\/art.39257","article-title":"A randomized, double-blind, placebo-controlled, 16-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis","volume":"67","author":"Sieper","year":"2015","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0235","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/1756-185X.12381","article-title":"Evaluation of Assessment of Spondyloarthritis International Society classification criteria for axial spondyloarthritis in Chinese patients with chronic back pain: results of a 2-year follow-up study","volume":"17","author":"Lin","year":"2014","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0240","article-title":"Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis","author":"Sepriano","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0245","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00296-014-2972-8","article-title":"Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity","volume":"34","author":"Haliloglu","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0250","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13075-016-0943-z","article-title":"Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis","volume":"18","author":"Bello","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0255","first-page":"24","article-title":"Clinical overlap between fibromyalgia tender points and enthesitis sites in patients with spondyloarthritis who present with inflammatory back pain","volume":"30","author":"Roussou","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0260","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/ard.2007.084244","article-title":"Development and validation of the Spondyloarthritis research consortium of Canada (SPARCC) Enthesitis Index","volume":"68","author":"Maksymowych","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0265","first-page":"117","article-title":"Rheumatoid arthritis and spondyloarthropathies: geographical variations in prevalence in France","volume":"34","author":"Roux","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0270","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1472-8206.2009.00730.x","article-title":"Medical and non-medical direct costs of chronic low back pain in patients consulting primary care physicians in France","volume":"24","author":"Depont","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0275","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jbspin.2008.06.002","article-title":"Fibromyalgia syndrome in the general population of France: a prevalence study","volume":"76","author":"Bannwarth","year":"2009","journal-title":"Jt Bone Spine Rev Rhum"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0280","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/rheumatology\/ket433","article-title":"Body weight, gender and response to TNF-\u03b1 blockers in axial spondyloarthritis","volume":"53","author":"Gremese","year":"2014","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0285","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3899\/jrheum.150648","article-title":"Obesity is common in axial spondyloarthritis and is associated with poor clinical outcome","volume":"43","author":"Maas","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0290","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/ar3841","article-title":"Body mass index influences the response to infliximab in ankylosing spondylitis","volume":"14","author":"Ottaviani","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0295","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/ard.2003.016386","article-title":"Prediction of a major clinical response (BASDAI\u00a050) to tumour necrosis factor blockers in ankylosing spondylitis","volume":"63","author":"Rudwaleit","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0300","doi-asserted-by":"crossref","first-page":"e000204","DOI":"10.1136\/rmdopen-2015-000204","article-title":"Factors associated with a bad functional prognosis in early inflammatory back pain: results from the DESIR cohort","volume":"2","author":"Lukas","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0305","article-title":"Impaired response to treatment with tumour necrosis factor inhibitors in smokers with axial spondyloarthritis","author":"Ciurea","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0310","first-page":"16","article-title":"Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab","author":"Lorenzin","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0315","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/art.24408","article-title":"Clinical and imaging efficacy of infliximab in HLA-B27-positive patients with magnetic resonance imaging-determined early sacroiliitis","volume":"60","author":"Barkham","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0320","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/annrheumdis-2012-202389","article-title":"Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1\u00a0year of treatment with etanercept: results from the ESTHER trial","volume":"72","author":"Song","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0325","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/BOR.0000000000000071","article-title":"Similarities and differences between nonradiographic and radiographic axial spondyloarthritis: a clinical, epidemiological and therapeutic assessment","volume":"26","author":"Poddubnyy","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0330","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/03009742.2014.918173","article-title":"Efficacy and drug survival of anti-tumour necrosis factor-alpha therapies in patients with non-radiographic axial spondyloarthritis: an observational cohort study from Southern Sweden","volume":"43","author":"Gulfe","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0335","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejrad.2013.10.001","article-title":"MRI of the SI joints commonly shows non-inflammatory disease in patients clinically suspected of sacroiliitis","volume":"83","author":"Jans","year":"2014","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jbspin.2017.08.005_bib0340","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.39551","article-title":"Associations between spondyloarthritis features and magnetic resonance imaging findings: a cross-sectional analysis of 1020\u00a0patients with persistent low back pain","volume":"68","author":"Arnbak","year":"2016","journal-title":"Arthritis Rheumatol Hoboken NJ"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X17301598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X17301598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T02:11:41Z","timestamp":1539569501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X17301598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1297319X17301598"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2017.08.005","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poor efficacy of TNF inhibitors in non-radiographic axial spondyloarthritis in the absence of objective signs: A bicentric retrospective study","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2017.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie.","name":"copyright","label":"Copyright"}]}}